M&A - DEALS NEWS - Acquisition of Ardena by GHO Capital

Global Healthcare Opportunities, or GHO Capital Partners LLP, the European specialist investor in healthcare, together with the existing management team has acquired Ardena, a specialist contract development and manufacturing organization (CDMO) focused on early phase drug development, from Mentha Capital.

Ardena is a multi-service CDMO, assisting small-to-mid sized biopharma with services spanning the full development life cycle. The Company offers a comprehensive ‘Make, Analyse, File’ model from drug substance and drug product manufacturing and bioanalytical services through to regulatory dossier development. Headquartered in Belgium, the company operates across several sites in the Netherlands, Sweden and Latvia. Mentha Capital is a leading private equity firm in the lower end of the mid-market in the Benelux.

It partners with established, mid-sized companies offering clear opportunities for accelerated growth (organic and through buy-&-build), global expansion and organizational transition. With over €400 million under management, Mentha Capital typically teams up with founders to realize ambitious growth plans.

Schoups advised the shareholders of Ardena.

For more information, please refer to the following press releases: Flanders.bio, Belgian Venture Capital & Private Equity Association, Business Wire, Bloomberg, Private Equity Wire, De Tijd and FD.